Bee, snake, and scorpion venom have cancer-fighting properties
the ONA take:
Finding reported at the 248th National Meeting of the American Chemical Society (ACS) suggest that bee, snake, or scorpion venom may be able to be used to fight cancer.
According to lead investigator Dipanjan Pan, Ph.D., the venom toxins within nanometer-sized particles were able to treat breast cancer and melanoma cells in vitro by remaining hidden from the immune system, thereby sparing normal cells and only killing cancer cells. This method eliminates adverse effects that venom toxins would typically cause.
Venom from these animals contains biological molecules that can attach to cancer cell membranes which would stop the growth and spread cancer. Because simply injecting venom into a patient would cause serious adverse effects like clotting, heart muscle or nerve cell damange, or bleeding under the skin, the anti-tumor substances within the venom had to be identified. One of those substances, melittin was chemically synthesized and inserted into nanoparticles.
The nanoparticles keep the toxin from seeping into the bloodstream and causing adverse effects. Pan says that the nanoparticles then go to the tumor where they attach to cancer stem cells, thereby blocking proliferation.
Future studies will evaluate this new method in rats and pigs, but Pan and his team hope they will eventually study the approach in patients in the next 3 to 5 years.
Bee, snake or scorpion venom could form the basis of a new generation of cancer-fighting drugs.
The report was part of the 248th National Meeting of the American Chemical Society (ACS), the world's largest scientific society.
The meeting, attended by thousands of scientists, features nearly 12,000 reports on new advances in science and other topics. It is being held here through Thursday.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|